Google’s Pixel Watch 3 is still down to a record low price, but honestly not everybody wants to — or even needs to — fork out ...

Texas Sinus & Snoring (346-413-9313), a practice that specializes in sinus conditions, has updated its treatments for sleep ...

Do you suffer from sleep apnea and long for a peaceful night’s sleep and solution to your snoring? Holy Cross Medical Group pulmonologist Ronald Scott, M.D. will speak about Inspire®, an FDA-approved ...

Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 55% bearish. Among these notable ...

Emma lives in Bogota, Colombia, where she owns the English-language newspaper The Bogota Post. She began her editorial career at a financial website in the U.K. over 20 years ago and has been ...

Inspire Medical Systems shares are up today on third-quarter results that came in ahead of the consensus forecast.

Inspire Medical Systems ( (INSP) ) has provided an update. Inspire Medical Systems reported a robust third quarter for 2024, with a 33% ...

Dr. Wise from CAMC not only offers ‘Inspire’ therapy to treat his patients' sleep apnea - he’s also using ‘Inspire’ to treat ...

Inspire Medical Systems (INSP) came out with quarterly earnings of $0.60 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.29 per share a year ago. These ...

Inspire Medical Systems topped Q3 expectations, signaling continued market strength and innovation.

Inspire is increasing its full year 2024 revenue guidance to between $793 million to $798 million, which represents growth of 27% to 28% over full year 2023 revenue of $624.8 million. This compares to ...